Literature DB >> 20053835

Dutch probiotics study is criticised for its "design, approval, and conduct".

Tony Sheldon.   

Abstract

Mesh：

Year:  2010        PMID： 20053835     DOI： 10.1136/bmj.c77

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Bugs or drugs: are probiotics safe for use in the critically ill?

Authors:  Lindsay M Urben; Jennifer Wiedmar; Erica Boettcher; Rodrigo Cavallazzi; Robert G Martindale; Stephen A McClave
Journal:  Curr Gastroenterol Rep       Date:  2014

2.  Use of pre-, pro- and synbiotics in patients with acute pancreatitis: a meta-analysis.

Authors:  Ming-Ming Zhang; Jing-Qiu Cheng; Yan-Rong Lu; Zhi-Hui Yi; Ping Yang; Xiao-Ting Wu
Journal:  World J Gastroenterol       Date:  2010-08-21       Impact factor: 5.742

Review 3.  Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis.

Authors:  William Manzanares; Margot Lemieux; Pascal L Langlois; Paul E Wischmeyer
Journal:  Crit Care       Date:  2016-08-19       Impact factor: 9.097

4.  Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial.

Authors:  Kentaro Shimizu; Tomoki Yamada; Hiroshi Ogura; Tomoyoshi Mohri; Takeyuki Kiguchi; Satoshi Fujimi; Takashi Asahara; Tomomi Yamada; Masahiro Ojima; Mitsunori Ikeda; Takeshi Shimazu
Journal:  Crit Care       Date:  2018-09-27       Impact factor: 9.097

Review 5.  Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective.

Authors:  Kentaro Shimizu; Hiroshi Ogura; Takashi Asahara; Koji Nomoto; Masami Morotomi; Osamu Tasaki; Asako Matsushima; Yasuyuki Kuwagata; Takeshi Shimazu; Hisashi Sugimoto
Journal:  Dig Dis Sci       Date:  2012-08-19       Impact factor: 3.199
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.